Triomics
Triomics builds AI agents that read the unstructured parts of a cancer patient's records, such as pathology reports and scanned faxes, to match patients to trials and prepare visits automatically.
Overview
Triomics provides AI infrastructure for oncology providers: large-language-model agents embedded in clinical workflows that process pathology reports, clinical notes, genomic panels and scanned documents in real time to support clinical trial matching, visit preparation and quality reporting. The company states that four of the top ten US News cancer hospitals and several of the largest community oncology practices use the platform. It has raised venture financing since YC; amounts are not recorded here because no primary source was fetched.
Funding
All startupsPages like this
not linked directly; found by shared links- CompanyAluna
Shares Y Combinator and the tag yc.
- CompanyLiyfe
Shares Y Combinator and the tag yc.
- CompanyMednet (theMednet)
Shares Y Combinator and the tag yc.
- CompanyREPROSENT
Shares Y Combinator and the tag yc.
- CompanyAlixia
Shares Y Combinator and the tag yc.
- CompanyVelorum Therapeutics
Shares Y Combinator and the tag yc.
- CompanyDelee
Shares Y Combinator and the tag yc.
- CompanyResistanceBio (Viosera Therapeutics)
Shares Y Combinator and the tag yc.